Other home-grown firms in virus fight
Local medical technology startup Respiree’s wearable device which is used to measure vital parameters such as respiratory rate or blood oxygen levels.
Local medical technology startup Respiree’s wearable device which is used to measure vital parameters such as respiratory rate or blood oxygen levels.
Digital tools that free up time and resources for clinical staff are a breath of fresh air in these pressing times – particularly when they can generate invaluable patient data. Roche Diagram magazine explores what these innovations mean for practitioners.
Founded in 2019, Respiree’s technology is based on core sensor technology developed at the Singapore Bioimaging Consortium (SBIC), at A*STAR. Gurpreet Singh, Founder of Respiree and A*STAR scholar, shares how he turned a discovery in the lab into a device that could potentially save lives.
Local medical technology start-up Respiree aims to deploy respiratory bio-markers to predict worsening conditions in Covid-19 patients in isolation rooms.
Early identification and therapeutic intervention are key to reducing risk for individuals at risk of acute respiratory failure and pneumonia from COVID-19 – such is the core of the collaboration between the National University Hospital (NUH), NUS Yong Loo Lin School of Medicine (NUS Medicine) and Respiree Pte Ltd.